Oruka Therapeutics, Inc. (HAN:HQ1) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James Flynn Other companies: Lite Strategy, Inc. (Non-Executive Director · Since at least Oct 31, 2023); Nuvalent, Inc. (Director · Since at least Jul 28, 2021); Larimar Therapeutics, Inc. (Director · Since at least May 28, 2020); Synlogic Inc (Director · Mar 19, 2024 – Apr 26, 2025 · Past); BiomX Inc. (Director · Mar 15, 2024 – Apr 21, 2025 · Past); RiceBran Technologies (Director · Jan 3, 2024 – Jan 3, 2024 · Past); CareMax Inc (Director · Nov 17, 2022 – Nov 17, 2023 · Past); ARS Pharmaceuticals, Inc. (Director · Nov 8, 2022 – Nov 8, 2022 · Past); Da32 Life Science Tech Acquisition Corp (Director · Jul 27, 2021 – Jul 28, 2023 · Past); Oncorus Inc (Director · Oct 1, 2020 – Feb 17, 2021 · Past); Acutus Medical Inc. (Director · Aug 5, 2020 – Jan 27, 2025 · Past); Deerfield Healthcare Technology Acquisitions Corp (Director · Jul 16, 2020 – Jul 21, 2020 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 6, 2019 · Past); AdaptHealth Corp. (Director · Feb 15, 2018 – Nov 8, 2019 · Past); Alpine Immune Sciences Inc (Director · Sep 12, 2016 – Sep 12, 2016 · Past); AveXis Inc (Director · Sep 3, 2015 – Feb 10, 2016 · Past) | Director · Dec 15, 2022 – Jan 30, 2024 · Past |
| Ted W Love Other companies: Lisata Therapeutics, Inc. (Director · Since at least Sep 17, 2026); Jazz Pharmaceuticals plc (Director · Since at least Dec 1, 2025); Gilead Sciences, Inc. (Director · Since at least Feb 1, 2024); Structure Therapeutics, Inc. (Director · Since at least Aug 3, 2023); Royalty Pharma plc (Director · Since at least Jul 30, 2020); Seagen Inc (Director · Aug 16, 2020 – Dec 14, 2023 · Past); Portola Pharmaceuticals Inc (Director · Sep 18, 2019 – Jul 2, 2020 · Past); Global Blood Therapeutics Inc (President and CEO, Director · Aug 11, 2015 – Oct 5, 2022 · Past); Cascadian Therapeutics Inc (Director · Sep 5, 2013 – Mar 9, 2018 · Past); Savara, Inc. (Director · Sep 5, 2012 – Jun 19, 2013 · Past); Humanigen Inc (Director · Aug 10, 2012 – Jul 10, 2015 · Past); Amicus Therapeutics Inc (Director · Jun 13, 2012 – Jun 4, 2020 · Past); Bio-Rad Laboratories, Inc. (Director · Mar 24, 2010 – Mar 24, 2010 · Past); Onyx Pharmaceuticals Inc (EVP, R&D and Tech. Operations · Feb 1, 2010 – Jul 25, 2012 · Past); Affymax Inc (Director · Dec 14, 2006 – Jun 13, 2012 · Past); Santarus Inc (Director · Jun 7, 2006 – Jan 2, 2014 · Past) | Director · Mar 7, 2006 – Feb 5, 2010 · Past |
| Kathryn Falberg Other companies: Nuvation Bio Inc. (Board of Directors · Since at least Feb 10, 2021); Arcus Biosciences, Inc. (Board Member · Since at least Mar 14, 2018); The Trade Desk, Inc. (Director · Since at least Sep 20, 2016); UroGen Pharma Ltd. (Director · Jan 1, 2019 – Jun 7, 2021 · Past); Tricida Inc (Director · Jun 27, 2018 – Jun 15, 2022 · Past); Sio Gene Therapies Inc (Director · Apr 7, 2017 – May 15, 2017 · Past); BioMarin Pharmaceutical Inc. (Director · Jul 15, 2016 – Jul 15, 2016 · Past); Aimmune Therapeutics Inc (Director · Aug 5, 2015 – Oct 10, 2020 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 24, 2016 · Past); Medivation Inc (Director · Jan 31, 2013 – Sep 28, 2016 · Past); Jazz Pharmaceuticals plc (EVP and CFO · Dec 1, 2009 – Mar 5, 2014 · Past); Novelion Therapeutics Inc (Director · Mar 25, 2009 – May 26, 2011 · Past); Halozyme Therapeutics, Inc. (Director · May 15, 2007 – May 4, 2016 · Past) | CFO and COO · Feb 23, 2009 – Jun 25, 2009 · Past |
| Peter Harwin Other companies: Alaunos Therapeutics, Inc. (Founding Partner, Fairmount Funds Management LLC · Since at least Oct 13, 2026); Damora Therapeutics, Inc. (Chairman of the Board · Since at least Nov 10, 2025); Crescent Biopharma, Inc. (Chair of Board · Since at least Jun 13, 2025); Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023); Spyre Therapeutics, Inc. (Director · Since at least Jun 22, 2023); Cogent Biosciences, Inc. (Founding Partner, Fairmount Funds Management LLC · Since at least Jul 6, 2020); Dianthus Therapeutics, Inc. (Director · Sep 11, 2023 – Jan 22, 2024 · Past); Viridian Therapeutics, Inc. (Director · Oct 27, 2020 – Jun 26, 2024 · Past) | Director · Since at least Aug 29, 2024 |
| Tomas Kiselak Other companies: Cyclerion Therapeutics, Inc. (Chairman · Since at least Apr 1, 2026); Crescent Biopharma, Inc. (Director · Since at least Jun 13, 2025); Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023); Spyre Therapeutics, Inc. (Director · Since at least Jun 22, 2023); Viridian Therapeutics, Inc. (Director · Since at least Oct 27, 2020); Dianthus Therapeutics, Inc. (Director · Sep 11, 2023 – Sep 27, 2024 · Past) | Director · Since at least Aug 29, 2024 |
| Jean-François Formela Other companies: Korro Bio, Inc. (Co-Founder & Director · Since at least Nov 3, 2023); ImageneBio, Inc. (Director · Mar 25, 2021 – Jun 7, 2024 · Past); Translate Bio Inc (Director · Jun 27, 2018 – Sep 14, 2021 · Past); Spero Therapeutics, Inc. (Director · Nov 1, 2017 – Aug 17, 2021 · Past); Intellia Therapeutics, Inc. (Director · May 5, 2016 – Jun 14, 2022 · Past); Egalet Corporation (Director · Feb 5, 2014 – Feb 11, 2014 · Past); Horizon Pharma PLC (Director · Jul 28, 2011 – Mar 2, 2012 · Past) | Director · Feb 10, 2012 – Oct 22, 2012 · Past |
| Linda S. Grais Other companies: ICON plc (Director · Since at least Mar 18, 2026); Corvus Pharmaceuticals, Inc. (Board Member · Since at least Jan 28, 2019); Deerfield Healthcare Technology Acquisitions Corp (Director · Jul 16, 2020 – Jul 16, 2020 · Past); Zosano Pharma Corp (Director · Jan 14, 2019 – Jun 10, 2021 · Past); PRA Health Sciences Inc (Director · Oct 9, 2015 – Jul 1, 2021 · Past); Ocera Therapeutics Inc (President and CEO, Director · Jul 15, 2013 – Dec 11, 2017 · Past) | Director · Jan 27, 2009 – Jan 30, 2024 · Past |
| Henry Ward Wolff Other companies: Sunesis Pharmaceuticals Inc (Director · Feb 2, 2018 – Jun 30, 2020 · Past); Calithera Biosciences, Inc. (Director · Dec 2, 2014 – Jun 1, 2022 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – Jul 2, 2020 · Past); Sangamo Therapeutics, Inc. (Exec VP & CFO · Jun 7, 2006 – Dec 12, 2016 · Past); Abgenix Inc (CFO & SVP, Finance · Mar 24, 2006 – Apr 1, 2006 · Past) | Sr. VP Finance and CFO · Jul 24, 2006 – Feb 1, 2007 · Past |
| Cameron Turtle Other companies: Damora Therapeutics, Inc. (Board Director · Since at least Mar 23, 2026); Spyre Therapeutics, Inc. (Chief Executive Officer · Since at least Jun 22, 2023); BridgeBio Pharma, Inc. (See Remarks · Jun 27, 2019 – Dec 28, 2020 · Past); Eidos Therapeutics Inc (Chief Business Officer · Nov 5, 2018 – Jan 26, 2021 · Past) | Director · Since at least Aug 29, 2024 |
| Kristine Ball Other companies: Enliven Therapeutics, Inc. (Member of the Board of Directors · Since at least Oct 14, 2026); Atreca Inc (Director · May 20, 2020 – Jun 13, 2023 · Past); Forty Seven Inc (Director · Jun 27, 2018 – Apr 7, 2020 · Past); Relypsa Inc (Chief Financial Officer & SVP · Nov 14, 2013 – Sep 1, 2016 · Past) | Director · Since at least Aug 29, 2024 |
| Lawrence Klein Other companies: Jade Biosciences, Inc. (Chief Executive Officer, Oruka Therapeutics · Since at least Apr 28, 2025); Jasper Therapeutics, Inc. (Director · Sep 24, 2021 – Jun 7, 2023 · Past); Dyne Therapeutics, Inc. (Director · Jul 31, 2020 – Jul 5, 2022 · Past); CRISPR Therapeutics AG (CBO & COO · Jan 2, 2019 – Aug 16, 2022 · Past) | Chief Executive Officer, Director · Since at least Aug 29, 2024 |
| Samarth Kulkarni Other companies: Centessa Pharmaceuticals PLC (Director · Since at least May 27, 2021); Black Diamond Therapeutics, Inc. (CEO, CRISPR Therapeutics AG · Since at least Jan 29, 2020); CRISPR Therapeutics AG (Chief Executive Officer and Chairman of the Board · Since at least Oct 18, 2016); Repare Therapeutics Inc (Director · Jun 18, 2020 – Jun 17, 2024 · Past) | Director · Since at least Aug 29, 2024 |
| Barry L Zubrow Other companies: Hudson Executive Investment Corp III (Director · Feb 23, 2021 – Feb 23, 2021 · Past); Arc Logistics Partners LP (Director · Dec 17, 2013 – Dec 21, 2017 · Past); JPMorgan Chase & Co. (Executive Vice President · Nov 30, 2007 – Oct 16, 2012 · Past) | Director · May 24, 2006 – May 31, 2007 · Past |
| Daniel J Mitchell Other companies: Globeimmune Inc (Director · Jul 1, 2014 – Mar 16, 2016 · Past); Cardiovascular Systems Inc (Director · Jun 27, 2006 – Dec 12, 2008 · Past); Myogen Inc (Director · Feb 2, 2006 – Nov 17, 2006 · Past) | Director · Feb 11, 2014 – Jan 30, 2024 · Past |
| Richard B Brewer Other companies: Myrexis Inc (President and CEO, Director · May 11, 2012 – May 11, 2012 · Past); Capricor Therapeutics, Inc. (Executive Chairman, Director · Jul 21, 2010 – Mar 30, 2012 · Past); Dendreon Corp (Director · Dec 6, 2006 – Jan 3, 2012 · Past) | Director · Jan 27, 2009 – Feb 10, 2012 · Past |
| Christopher Martin Other companies: Achieve Life Sciences, Inc. (Director · Since at least May 11, 2026); Edgewise Therapeutics, Inc. (Director · Since at least Nov 19, 2025) | Director · Since at least Dec 11, 2025 |
| Gary Titus Other companies: SciClone Pharmaceuticals Inc (Senior VP Finance & CFO · Dec 8, 2008 – May 31, 2012 · Past); Kosan Biosciences Inc (Sr. VP and CFO · Sep 5, 2006 – Jun 26, 2008 · Past) | Chief Acct.Officer · Aug 1, 2006 – Aug 30, 2006 · Past |
| Carl Dambkowski Other companies: Apogee Therapeutics, Inc. (Chief Medical Officer · Since at least Jul 13, 2023) | Director · Since at least Aug 29, 2024 |
| Joana Goncalves Other companies: Tvardi Therapeutics, Inc. (CHIEF MEDICAL OFFICER · Oct 22, 2018 – Apr 5, 2024 · Past) | Chief Medical Officer · Since at least Aug 29, 2024 |
| John L Zabriskie Other companies: Macrochem Corp (Director · Sep 5, 2007 – Sep 5, 2007 · Past) | Director · Jan 27, 2009 – Sep 17, 2013 · Past |
| Larry Todd Edwards Other companies: Arcutis Biotherapeutics, Inc. (See Remarks · Since at least Sep 27, 2023) | Chief Commercial Officer · Since at least Aug 24, 2026 |
| Mary K Pendergast Other companies: Impax Laboratories Inc (Director · Jul 3, 2013 – May 4, 2018 · Past) | Director · May 24, 2006 – Feb 5, 2010 · Past |
| Paul T Quinlan Other companies: Terravia Holdings Inc (General Counsel · May 26, 2011 – Mar 9, 2017 · Past) | General Counsel · Since at least Aug 29, 2024 |
| Robert E Conway Other companies: Alpine Immune Sciences Inc (Director · Jun 16, 2015 – May 20, 2024 · Past) | Director · Sep 3, 2013 – Jan 30, 2024 · Past |
| Thomas A Keuer Other companies: Insmed Incorporated (Senior VP, Operations (sub) · Dec 31, 2005 – Dec 31, 2005 · Past) | Chief Operating Officer · Dec 30, 2014 – Dec 8, 2022 · Past |
| Anders D Hove | Director · Mar 1, 2018 – Jan 30, 2024 · Past |
| Arjun Agarwal | Senior Vice President, Finance · Since at least Aug 29, 2024 |
| Brian L Selby | VP, Finance · Dec 30, 2014 – Dec 21, 2020 · Past |
| Chris Martin | Director · Since at least Dec 11, 2025 |
| Christopher David Ozeroff | S.V.P., General Counsel · May 26, 2010 – Dec 14, 2021 · Past |
| C Jeffrey Dekker | Chief Financial Officer · May 10, 2021 – Dec 8, 2022 · Past |
| E Lee Bendekgey | CFO and Treasurer · Aug 1, 2006 – Dec 31, 2008 · Past |
| Jacob Ma-Weaver | Director · Jun 15, 2022 – Jan 30, 2024 · Past |
| Laura Lee Sandler | Chief Operating Officer · Since at least Jul 1, 2025 |
| Michael D Levy | Executive Vice President · Aug 1, 2006 – Feb 1, 2008 · Past |
| Michael R Bristow | Pres. & Chief Executive Offic, Director · Dec 21, 2020 – Dec 14, 2021 · Past |
| Patrick M Wheeler | Chief Financial Officer · Dec 7, 2009 – Sep 18, 2014 · Past |
| Randall St Laurent | EVP Commercial Operations · Jan 27, 2009 – Jan 27, 2009 · Past |
| Raymond L Woosley | Director · Jul 26, 2013 – Jan 30, 2024 · Past |
| Todd Edwards | Chief Commercial Officer · Since Aug 24, 2026 |